Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Potassium ion binding refers to the molecular interaction where proteins, channels, or agents selectively recognize and bind potassium ions (K+). In the context of hyperkalemia—an elevated level of potassium in the blood—this process is clinically significant for both physiological regulation and therapeutic intervention. Therapeutic strategies target excess free K+ using potassium binders like patiromer or sodium polystyrene sulfonate, which bind free intestinal K+, promoting its fecal excretion and lowering serum levels.
Ionic exchange with resins in the gut.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium Ion Binding (None).